Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population

被引:0
|
作者
Margaret L. Lind
Murilo Dorion
Amy J. Houde
Mary Lansing
Sarah Lapidus
Russell Thomas
Inci Yildirim
Saad B. Omer
Wade L. Schulz
Jason R. Andrews
Matt D. T. Hitchings
Byron S. Kennedy
Robert P. Richeson
Derek A. T. Cummings
Albert I. Ko
机构
[1] Yale School of Public Health,Department of Epidemiology of Microbial Diseases
[2] Connecticut Department of Correction,Department of Internal Medicine
[3] Department of Pediatrics,Department of Laboratory Medicine
[4] Yale School of Medicine,Division of Infectious Diseases and Geographic Medicine
[5] Yale Institute for Global Health,Department of Biostatistics, College of Public Health & Health Professions
[6] Yale School of Public Health,Department of Biology
[7] UT Southwestern,Emerging Pathogens Institute
[8] School of Public Health,undefined
[9] Yale School of Medicine,undefined
[10] Yale University School of Medicine,undefined
[11] Stanford University,undefined
[12] University of Florida,undefined
[13] University of Florida,undefined
[14] University of Florida,undefined
[15] Instituto Gonçalo Moniz,undefined
[16] Fundação Oswaldo Cruz,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Whether SARS-CoV-2 infection and COVID-19 vaccines confer exposure-dependent (“leaky”) protection against infection remains unknown. We examined the effect of prior infection, vaccination, and hybrid immunity on infection risk among residents of Connecticut correctional facilities during periods of predominant Omicron and Delta transmission. Residents with cell, cellblock, and no documented exposure to SARS-CoV-2 infected residents were matched by facility and date. During the Omicron period, prior infection, vaccination, and hybrid immunity reduced the infection risk of residents without a documented exposure (HR: 0.36 [0.25–0.54]; 0.57 [0.42–0.78]; 0.24 [0.15–0.39]; respectively) and with cellblock exposures (0.61 [0.49–0.75]; 0.69 [0.58–0.83]; 0.41 [0.31–0.55]; respectively) but not with cell exposures (0.89 [0.58–1.35]; 0.96 [0.64–1.46]; 0.80 [0.46–1.39]; respectively). Associations were similar during the Delta period and when analyses were restricted to tested residents. Although associations may not have been thoroughly adjusted due to dataset limitations, the findings suggest that prior infection and vaccination may be leaky, highlighting the potential benefits of pairing vaccination with non-pharmaceutical interventions in crowded settings.
引用
收藏
相关论文
共 50 条
  • [1] Evidence of leaky protection following COVID-19 vaccination and SARS-CoV-2 infection in an incarcerated population
    Lind, Margaret L.
    Dorion, Murilo
    Houde, Amy J.
    Lansing, Mary
    Lapidus, Sarah
    Thomas, Russell
    Yildirim, Inci
    Omer, Saad B.
    Schulz, Wade L.
    Andrews, Jason R.
    Hitchings, Matt D. T.
    Kennedy, Byron S.
    Richeson, Robert P.
    Cummings, Derek A. T.
    Ko, Albert I.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [2] Protection against SARS-CoV-2 after COVID-19 vaccination and previous infection
    Israeli, Eitan
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (04): : 211 - 211
  • [3] Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
    Hall, Victoria
    Foulkes, Sarah
    Insalata, Ferdinando
    Kirwan, Peter
    Saei, Ayoub
    Atti, Ana
    Wellington, Edgar
    Khawam, Jameel
    Munro, Katie
    Cole, Michelle
    Tranquillini, Caio
    Taylor-Kerr, Andrew
    Hettiarachchi, Nipunadi
    Calbraith, Davina
    Sajedi, Noshin
    Milligan, Iain
    Themistocleous, Yrene
    Corrigan, Diane
    Cromey, Lisa
    Price, Lesley
    Stewart, Sally
    de Lacy, Elen
    Norman, Chris
    Linley, Ezra
    Otter, Ashley D.
    Semper, Amanda
    Hewson, Jacqueline
    D'Arcangelo, Silvia
    Chand, Meera
    Brown, Colin S.
    Brooks, Tim
    Islam, Jasmin
    Charlett, Andre
    Hopkins, Susan
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (13): : 1207 - 1220
  • [4] SARS-CoV-2 infection and COVID-19 vaccination in pregnancy
    Victoria Male
    Nature Reviews Immunology, 2022, 22 : 277 - 282
  • [5] SARS-CoV-2 infection and COVID-19 vaccination in pregnancy
    Male, Victoria
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (05) : 277 - 282
  • [6] Risk of SARS-COV-2 infection following initial COVID-19 vaccination by location
    Tadrous, Mina
    Chu, Cherry
    Campbell, Tonya
    Juurlink, Dave
    Kwong, Jeff
    Paterson, Michael
    Gomes, Tara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 621 - 622
  • [7] Anti-S2 Protection in COVID-19 Infection and SARS-CoV-2 Spike Vaccination
    Canziani, Gabriela A.
    Tang, Jackie
    Nangarlia, Aakansha
    Zhang, Shiyu
    Fazloon-Hassen, Farah
    Taludker, Choya
    Connors, Jennifer
    Cusimano, Gina
    Bernui, Mariana
    Bell, Matt
    FASEB JOURNAL, 2022, 36
  • [8] Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination
    Sekulovski, Metodija
    Mileva, Niya
    Vasilev, Georgi Vasilev
    Miteva, Dimitrina
    Gulinac, Milena
    Peshevska-Sekulovska, Monika
    Chervenkov, Lyubomir
    Batselova, Hristiana
    Vasilev, Georgi Hristov
    Tomov, Latchezar
    Lazova, Snezhina
    Vassilev, Dobrin
    Velikova, Tsvetelina
    BIOMEDICINES, 2023, 11 (10)
  • [9] Effect of COVID-19 vaccination on thromboembolic and cardiovascular complications following SARS-CoV-2 infection
    Mercade Besora, Nuria
    Jodicke, Annika M.
    Roel, Elena
    Delmestri, Antonella
    Prats, Clara
    Prieto-Alhambra, Daniel
    Catala Sabate, Marti
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 43 - 43
  • [10] Immune response to COVID-19 vaccination in a population with and without a previous SARS-CoV-2 infection
    Mary Duro
    Cristina Almeida
    Inês Duro
    Amélia Sarmento
    Irish Journal of Medical Science (1971 -), 2023, 192 : 731 - 739